Literature DB >> 28289030

Antibiotic Prophylaxis Is Associated with Subsequent Resistant Infections in Children with an Initial Extended-Spectrum-Cephalosporin-Resistant Enterobacteriaceae Infection.

Sibani Das1, Amanda L Adler2, Arianna Miles-Jay3,2, Matthew P Kronman4,2, Xuan Qin5,2, Scott J Weissman4,2, C A Burnham6,7, Alexis Elward8,7, Jason G Newland9,10, Rangaraj Selvarangan11,10, Kaede V Sullivan12,13, Theoklis Zaoutis14,13, Danielle M Zerr15,2.   

Abstract

The objective of this study was to assess the association between previous antibiotic use, particularly long-term prophylaxis, and the occurrence of subsequent resistant infections in children with index infections due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae We also investigated the concordance of the index and subsequent isolates. Extended-spectrum-cephalosporin-resistant Escherichia coli and Klebsiella spp. isolated from normally sterile sites of patients aged <22 years were collected along with associated clinical data from four freestanding pediatric centers. Subsequent isolates were categorized as concordant if the species, resistance determinants, and fumC-fimH (E. coli) or tonB (Klebsiella pneumoniae) type were identical to those of the index isolate. In total, 323 patients had 396 resistant isolates; 45 (14%) patients had ≥1 subsequent resistant infection, totaling 73 subsequent resistant isolates. The median time between the index and first subsequent infections was 123 (interquartile range, 43 to 225) days. In multivariable Cox proportional hazards analyses, patients were 2.07 times as likely to have a subsequent resistant infection (95% confidence interval, 1.11 to 3.87) if they received prophylaxis in the 30 days prior to the index infection. In 26 (58%) patients, all subsequent isolates were concordant with their index isolate, and 7 (16%) additional patients had at least 1 concordant subsequent isolate. In 12 of 17 (71%) patients with E. coli sequence type 131 (ST131)-associated type 40-30, all subsequent isolates were concordant. Subsequent extended-spectrum-cephalosporin-resistant infections are relatively frequent and are most commonly due to bacterial strains concordant with the index isolate. Further study is needed to assess the role prophylaxis plays in these resistant infections.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  antibiotic resistance; pediatric infectious disease

Mesh:

Substances:

Year:  2017        PMID: 28289030      PMCID: PMC5404513          DOI: 10.1128/AAC.02656-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 2.  Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review.

Authors:  N Le Saux; B Pham; D Moher
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

3.  Antibiotic resistance patterns of community-acquired urinary tract infections in children with vesicoureteral reflux receiving prophylactic antibiotic therapy.

Authors:  Chi-Hui Cheng; Ming-Horng Tsai; Yhu-Chering Huang; Lin-Hui Su; Yong-Kwei Tsau; Chi-Jen Lin; Cheng-Hsun Chiu; Tzou-Yien Lin
Journal:  Pediatrics       Date:  2008-12       Impact factor: 7.124

4.  Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.

Authors:  Danielle M Zerr; Arianna Miles-Jay; Matthew P Kronman; Chuan Zhou; Amanda L Adler; Wren Haaland; Scott J Weissman; Alexis Elward; Jason G Newland; Theoklis Zaoutis; Xuan Qin
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

5.  Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.

Authors:  Noam Dayan; Husein Dabbah; Irith Weissman; Ibrahim Aga; Lea Even; Daniel Glikman
Journal:  J Pediatr       Date:  2013-08-03       Impact factor: 4.406

6.  The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts.

Authors:  James R Johnson; Paul Thuras; Brian D Johnston; Scott J Weissman; Ajit P Limaye; Kim Riddell; Delia Scholes; Veronika Tchesnokova; Evgeni Sokurenko
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079

7.  Increasing Incidence of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States.

Authors:  Joshua T Thaden; Vance G Fowler; Daniel J Sexton; Deverick J Anderson
Journal:  Infect Control Hosp Epidemiol       Date:  2015-10-13       Impact factor: 3.254

8.  Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts.

Authors:  Ritu Banerjee; Brian Johnston; Christine Lohse; Stephen B Porter; Connie Clabots; James R Johnson
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-13       Impact factor: 3.254

9.  The Molecular and Clinical Epidemiology of Extended-Spectrum Cephalosporin- and Carbapenem-Resistant Enterobacteriaceae at 4 US Pediatric Hospitals.

Authors:  Danielle M Zerr; Scott J Weissman; Chuan Zhou; Matthew P Kronman; Amanda L Adler; Jessica E Berry; Jaipreet Rayar; Jeff Myers; Wren L Haaland; Carey-Ann D Burnham; Alexis Elward; Jason Newland; Rangaraj Selvarangan; Kaede V Sullivan; Theoklis Zaoutis; Xuan Qin
Journal:  J Pediatric Infect Dis Soc       Date:  2017-11-24       Impact factor: 3.164

10.  Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology.

Authors:  Maria José Espinar; Isabel M Miranda; Sofia Costa-de-Oliveira; Rita Rocha; Acácio G Rodrigues; Cidália Pina-Vaz
Journal:  PLoS One       Date:  2015-08-03       Impact factor: 3.240

View more
  5 in total

1.  A Decision Tree Using Patient Characteristics to Predict Resistance to Commonly Used Broad-Spectrum Antibiotics in Children With Gram-Negative Bloodstream Infections.

Authors:  Anna C Sick-Samuels; Katherine E Goodman; Glenn Rapsinski; Elizabeth Colantouni; Aaron M Milstone; Andrew J Nowalk; Pranita D Tamma
Journal:  J Pediatric Infect Dis Soc       Date:  2020-04-30       Impact factor: 3.164

2.  Heterogeneous-Backbone Proteomimetic Analogues of Lasiocepsin, a Disulfide-Rich Antimicrobial Peptide with a Compact Tertiary Fold.

Authors:  Chino C Cabalteja; Qiao Lin; Thomas W Harmon; Shilpa R Rao; Y Peter Di; W Seth Horne
Journal:  ACS Chem Biol       Date:  2022-03-15       Impact factor: 4.634

3.  Epidemiology and Antimicrobial Resistance Characteristics of the Sequence Type 131-H30 Subclone Among Extraintestinal Escherichia coli Collected From US Children.

Authors:  Arianna Miles-Jay; Scott J Weissman; Amanda L Adler; Veronika Tchesnokova; Evgeni V Sokurenko; Janet G Baseman; Danielle M Zerr
Journal:  Clin Infect Dis       Date:  2018-01-18       Impact factor: 9.079

4.  Multi-Drug Resistant Escherichia coli Causing Early-Onset Neonatal Sepsis - a Single Center Experience from China.

Authors:  Minli Zhu; Yuting Jin; Yue Duan; Minzhi He; Zhenlang Lin; Jing Lin
Journal:  Infect Drug Resist       Date:  2019-11-27       Impact factor: 4.003

5.  High prevalence of blaCTX-M and blaSHV among ESBL producing E. coli isolates from beef cattle in China's Sichuan-Chongqing Circle.

Authors:  Yu-Long Zhang; Fang-Yuan Huang; Lin-Li Gan; Xin Yu; Dong-Jie Cai; Jing Fang; Zhi-Jun Zhong; Hong-Rui Guo; Yue Xie; Jun Yi; Zhi-Sheng Wang; Zhi-Cai Zuo
Journal:  Sci Rep       Date:  2021-07-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.